{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:57:10Z","timestamp":1780505830213,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700903"],"award-info":[{"award-number":["2021YFC2700903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05005-5","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:25:49Z","timestamp":1724423149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical features and CPS1 variants in Chinese patients with carbamoyl phosphate synthetase 1 deficiency"],"prefix":"10.1186","volume":"24","author":[{"given":"Hui","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingding","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"5005_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ymgme.2020.10.003","volume":"131","author":"M Nitzahn","year":"2020","unstructured":"Nitzahn M, Lipshutz GS. CPS1: looking at an ancient enzyme in a modern light. Mol Genet Metab. 2020;131:289\u201398. https:\/\/doi.org\/10.1016\/j.ymgme.2020.10.003.","journal-title":"Mol Genet Metab"},{"key":"5005_CR2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/jdn.10229","volume":"82","author":"FF Lopes","year":"2022","unstructured":"Lopes FF, Sitta A, de Moura Coelho D, Ribas GS, Faverzani JL, Dos Reis BG, et al. Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy. Int J Dev Neurosci. 2022;82:772\u201388. https:\/\/doi.org\/10.1002\/jdn.10229.","journal-title":"Int J Dev Neurosci"},{"key":"5005_CR3","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1007\/s10571-021-01156-6","volume":"42","author":"GS Ribas","year":"2022","unstructured":"Ribas GS, Lopes FF, Deon M, Vargas CR. Hyperammonemia in inherited metabolic diseases. Cell Mol Neurobiol. 2022;42:2593\u2013610. https:\/\/doi.org\/10.1007\/s10571-021-01156-6.","journal-title":"Cell Mol Neurobiol"},{"key":"5005_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jmd2.12091","volume":"52","author":"J Isler","year":"2020","unstructured":"Isler J, R\u00fcfenacht V, Gemperle C, Allegri G, Haberle J. Improvement of diagnostic yield in carbamoylphosphate synthetase 1 (CPS1) molecular genetic investigation by RNA sequencing. JIMD Rep. 2020;52:28\u201334. https:\/\/doi.org\/10.1002\/jmd2.12091.","journal-title":"JIMD Rep"},{"key":"5005_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13023-017-0661-x","volume":"12","author":"S Nettesheim","year":"2017","unstructured":"Nettesheim S, Kolker S, Karall D, Haberle J, Posset R, Hoffmann GF, et al. Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland. Orphanet J Rare Dis. 2017;12:111\u20138. https:\/\/doi.org\/10.1186\/s13023-017-0661-x.","journal-title":"Orphanet J Rare Dis"},{"key":"5005_CR6","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1056\/NEJMoa066596","volume":"356","author":"GM Enns","year":"2007","unstructured":"Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med. 2007;356:2282\u201392. https:\/\/doi.org\/10.1056\/NEJMoa066596.","journal-title":"N Engl J Med"},{"key":"5005_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","volume":"110","author":"ML Summar","year":"2013","unstructured":"Summar ML, Koelker S, Freedenberg D, Le Mons C, Haberle J, Lee HS, et al. The incidence of urea cycle disorders. Mol Genet Metab. 2013;110:179\u201380. https:\/\/doi.org\/10.1016\/j.ymgme.2013.07.008.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"5005_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ymgme.2010.08.002","volume":"101","author":"AI Martinez","year":"2010","unstructured":"Martinez AI, Perez-Arellano I, Pekkala S, Barcelona B, Cervera J. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency. Mol Genet Metab. 2010;101(4):311\u201323. https:\/\/doi.org\/10.1016\/j.ymgme.2010.08.002.","journal-title":"Mol Genet Metab"},{"key":"5005_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22241","volume":"32","author":"G Zhang","year":"2018","unstructured":"Zhang G, Chen Y, Ju H, Li X, Liu Y, Bei F, Li J, Wang J, et al. Carbamoyl phosphate synthetase 1 deficiency diagnosed by whole exome sequencing. J Clin Lab Anal. 2018;32: e22241. https:\/\/doi.org\/10.1002\/jcla.22241.","journal-title":"J Clin Lab Anal"},{"key":"5005_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22375","volume":"32","author":"X Chen","year":"2018","unstructured":"Chen X, Yuan L, Sun M, Liu Q, Wu Y. Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy. J Clin Lab Anal. 2018;32: e22375. https:\/\/doi.org\/10.1002\/jcla.22375.","journal-title":"J Clin Lab Anal"},{"key":"5005_CR11","doi-asserted-by":"publisher","first-page":"1025572","DOI":"10.3389\/fnins.2022.1025572","volume":"16","author":"R Bai","year":"2022","unstructured":"Bai R, He A, Guo J, Li Z, Yu X, Zeng J, et al. Novel pathogenic variant (c.2947C\u2009>\u2009T) of the carbamoyl phosphate synthetase 1 gene in neonatal-onset deficiency. Front Neurosci. 2022;16:1025572. https:\/\/doi.org\/10.3389\/fnins.2022.1025572.","journal-title":"Front Neurosci"},{"key":"5005_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"5005_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23124","volume":"34","author":"L Fan","year":"2020","unstructured":"Fan L, Zhao J, Jiang L, Xie L, Ma J, Li X, et al. Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency. J Clin Lab Anal. 2020;34: e23124. https:\/\/doi.org\/10.1002\/jcla.23124.","journal-title":"J Clin Lab Anal"},{"key":"5005_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/humu.22460","volume":"35","author":"JL Rodriguez-Flores","year":"2014","unstructured":"Rodriguez-Flores JL, Fakhro K, Hackett NR, Salit J, Fuller J, Agosto-Perez F, et al. Exome sequencing identifies potential risk variants for mendelian disorders at high prevalence in Qatar. Hum Mutat. 2014;35:105\u201316. https:\/\/doi.org\/10.1002\/humu.22460.","journal-title":"Hum Mutat"},{"issue":"8","key":"5005_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575\u20136. https:\/\/doi.org\/10.1038\/nmeth0810-575.","journal-title":"Nat Methods"},{"issue":"4","key":"5005_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139. https:\/\/doi.org\/10.1038\/nmeth0410-248.","journal-title":"Nat Methods"},{"issue":"7","key":"5005_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381. https:\/\/doi.org\/10.1038\/nprot.2009.86.","journal-title":"Nat Protoc"},{"issue":"19","key":"5005_CR18","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.26355\/eurrev_202010_23220","volume":"24","author":"G Imataka","year":"2020","unstructured":"Imataka G, Ishii J, Ando Y, Yoshihara S, Takagi Y, Nitta A, Arisaka O, Yoshihara S. Long-term survival of a patient with acute neonatal-onset metabolic encephalopathy with carbamoyl phosphate synthetase 1 deficiency. Eur Rev Med Pharmacol Sci. 2020;24(19):10051\u20133. https:\/\/doi.org\/10.26355\/eurrev_202010_23220.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5005_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cca.2021.11.029","volume":"526","author":"Y Choi","year":"2022","unstructured":"Choi Y, Oh A, Lee Y, Kim GH, Choi JH, Yoo HW, et al. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency. Clin Chim Acta. 2022;526:55\u201361. https:\/\/doi.org\/10.1016\/j.cca.2021.11.029.","journal-title":"Clin Chim Acta"},{"key":"5005_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","volume":"64","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto S, Haberle J, Kido J, Mitsubuchi H, Endo F, Nakamura K. Urea cycle disorders-update. J Hum Genet. 2019;64:833\u201347. https:\/\/doi.org\/10.1038\/s10038-019-0614-4.","journal-title":"J Hum Genet"},{"key":"5005_CR21","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J Haberle","year":"2019","unstructured":"Haberle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42:1192\u2013230. https:\/\/doi.org\/10.1002\/jimd.12100.","journal-title":"J Inherit Metab Dis"},{"key":"5005_CR22","doi-asserted-by":"publisher","first-page":"100942","DOI":"10.1016\/j.ymgmr.2022.100942","volume":"33","author":"HT Lin","year":"2022","unstructured":"Lin HT, Enchautegui-Colon Y, Huang YR, Zimmerman C, DeMarzo D, Tsai AC. Novel compound heterozygote variants: c.4193_4206delinsG (p.Leu1398Argfs*25), c.793C > A (p.Pro265Thr), in the CPS1 gene (NM_001875.4) causing late onset carbamoyl phosphate synthetase 1 deficiency-lessons learned. Mol Genet Metab Rep. 2022;33:100942. https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100942.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"5005_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00431-015-2644-z","volume":"175","author":"EZ Ali","year":"2016","unstructured":"Ali EZ, Khalid MK, Yunus ZM, Yakob Y, Chin CB, Abd Latif K, et al. Carbamoylphosphate synthetase 1 (CPS1) deficiency: clinical, biochemical, and molecular characterization in Malaysian patients. Eur J Pediatr. 2016;175(3):339\u201346.","journal-title":"Eur J Pediatr"},{"key":"5005_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3389\/fgene.2019.00718","volume":"10","author":"B Yan","year":"2019","unstructured":"Yan B, Wang C, Zhang K, Zhang H, Gao M, Lv Y, et al. Novel neonatal variants of the carbamoyl phosphate synthetase 1 deficiency: two case reports and review of literature. Front Genet. 2019;10:718\u201328. https:\/\/doi.org\/10.3389\/fgene.2019.00718.","journal-title":"Front Genet"},{"issue":"2","key":"5005_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ymgme.2014.04.003","volume":"112","author":"C Diez-Fernandez","year":"2014","unstructured":"Diez-Fernandez C, Hu L, Cervera J, Haberle J, Rubio V. Understanding carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function. Mol Genet Metab. 2014;112(2):123\u201332. https:\/\/doi.org\/10.1016\/j.ymgme.2014.04.003.","journal-title":"Mol Genet Metab"},{"key":"5005_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12987","volume":"21","author":"J Kido","year":"2017","unstructured":"Kido J, Matsumoto S, Momosaki K, Sakamoto R, Mitsubuchi H, Endo F, et al. Liver transplantation may prevent neurodevelopmental deterioration in high-risk patients with urea cycle disorders. Pediatr Transpl. 2017;21: e12987. https:\/\/doi.org\/10.1111\/petr.12987.","journal-title":"Pediatr Transpl"},{"key":"5005_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10545-011-9427-0","volume":"35","author":"J Kido","year":"2012","unstructured":"Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, et al. Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis. 2012;35:777\u201385. https:\/\/doi.org\/10.1007\/s10545-011-9427-0.","journal-title":"J Inherit Metab Dis"},{"key":"5005_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jmd2.12034","volume":"48","author":"S Yap","year":"2019","unstructured":"Yap S, Gougeard N, Hart AR, Barcelona B, Rubio V. N-carbamoylglutamate-responsive carbamoyl phosphate synthetase 1 (CPS1) deficiency: a patient with a novel CPS1 mutation and an experimental study on the mutation\u2019s effects. JIMD Rep. 2019;48:36\u201344. https:\/\/doi.org\/10.1002\/jmd2.12034.","journal-title":"JIMD Rep"},{"key":"5005_CR29","doi-asserted-by":"publisher","first-page":"100622","DOI":"10.1016\/j.ymgmr.2020.100622","volume":"24","author":"Y Sugiyama","year":"2020","unstructured":"Sugiyama Y, Shimura M, Ogawa-Tominaga M, Ebihara T, Kinouchi Y, Isozaki K, et al. Therapeutic effect of N-carbamylglutamate in CPS1 deficiency. Mol Genet Metab Rep. 2020;24:100622. https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100622.","journal-title":"Mol Genet Metab Rep"},{"issue":"9","key":"5005_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1515\/jpem-2023-0210","volume":"36","author":"V Gragnaniello","year":"2023","unstructured":"Gragnaniello V, Gueraldi D, Puma A, Commone A, Loro C, Cazzorla C, et al. Variant in the allosteric domain of CPS1 protein associated with effectiveness of N-carbamoyl glutamate therapy in neonatal onset CPS1 deficiency. J Pediatr Endocrinol Metab. 2023;36(9):873\u20138.","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05005-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05005-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05005-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:27:00Z","timestamp":1724423220000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05005-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5005"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05005-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"28 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Institutional Ethics Committee of Peking University First Hospital and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the guardians of all patients in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"539"}}